Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic

The COVID-19 pandemic, while putting pressure on the global healthcare system, has had a significant impact on the prevention, diagnosis, and treatment of cervical cancer. The aim of this study is to provide an overview of the challenges and opportunities presented to cervical cancer during the COVI...

Full description

Saved in:
Bibliographic Details
Published in:Infectious agents and cancer 2024-08, Vol.19 (1), p.41-7, Article 41
Main Authors: Dong, Shixiang, Wang, Yankui, Ding, Yu
Format: Article
Language:English
Subjects:
Anxiety
Cancer
Cancer screening
Cancer therapies
Care and treatment
Cervical cancer
Coronaviruses
COVID-19
COVID-19 vaccines
Developing countries
Diagnosis
Disease management
Disease prevention
Diseases
Eradication
Global health
Health aspects
Hospitals
HPV
Human papillomavirus
Immunization
LDCs
Medical screening
Oncology, Experimental
Pandemics
Papillomavirus infections
Patients
Prevention
Review
Severe acute respiratory syndrome coronavirus 2
Testing laboratories
Womens health
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic, while putting pressure on the global healthcare system, has had a significant impact on the prevention, diagnosis, and treatment of cervical cancer. The aim of this study is to provide an overview of the challenges and opportunities presented to cervical cancer during the COVID-19 pandemic and to provide lessons for better coping with cervical cancer in future pandemics. The search terms included the following: SARS-CoV-2 and/or COVID-19 with cervical cancer and HPV. The initial literature search began on June 1, 2022 and ended on March 1, 2023. COVID-19 has hindered the cervical cancer screening, delayed the diagnosis and treatment of cervical cancer, increased the public's anxiety, and negatively affected the management of cervical cancer. However, the occurrence of COVID-19 pandemic has promoted the development of new human papillomavirus (HPV) tests and improved the rates of HPV self-sampling, offering a small window of opportunity to eliminate cervical cancer. In the next few years, the COVID-19 pandemic will come to an end, and the eradication of cervical cancer should always be carried out. We should draw lessons and experience from this global pandemic, and make efforts for the subsequent eradication of cervical cancer.
ISSN:1750-9378
1750-9378
DOI:10.1186/s13027-024-00594-3